APO Research
Talk to an analyst

APO RESEARCH · REPORT

Endocrinology Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Endocrinology Drugs Market Outlook and Growth Opportunities 2026

22 December 2025193 pages

Choose your research edition.

Industry ResearchEndocrinology Drugs Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Endocrinology Drugs Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Endocrinology Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endocrinology Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Endocrinology Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Endocrinology Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Endocrinology Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Endocrinology Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Endocrinology Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Endocrinology Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Endocrinology Drugs market include Sanofi, Novo Nordisk, Merck, Eli Lilly, AbbVie and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Endocrinology Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Endocrinology Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Endocrinology Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Endocrinology Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Endocrinology Drugs Segment by Company

Sanofi

Novo Nordisk

Merck

Eli Lilly

AbbVie

AstraZeneca

Endocrinology Drugs Segment by Type

Diabetes Drugs

Human Growth Hormone Drugs

Thyroid Hormone Disorder Drugs

Testosterone Replacement Drugs

Endocrinology Drugs Segment by Application

Ambulatory Care Centres

Commercial Laboratories

Hospitals

Other Setting

Endocrinology Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Endocrinology Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Endocrinology Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Endocrinology Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Endocrinology Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endocrinology Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endocrinology Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endocrinology Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Endocrinology Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Endocrinology Drugs industry.

Chapter 3: Detailed analysis of Endocrinology Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Endocrinology Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Endocrinology Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Endocrinology Drugs Industry Trends Table 2. Endocrinology Drugs Industry Drivers Table 3. Endocrinology Drugs Industry Opportunities and Challenges Table 4. Endocrinology Drugs Industry Restraints Table 5. Global Endocrinology Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Endocrinology Drugs Revenue Share by Company (2021-2026) Table 7. Global Endocrinology Drugs Sales Volume by Company (k units) & (2021-2026) Table 8. Global Endocrinology Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Endocrinology Drugs Average Price (US$/unit) of Company (2021-2026) Table 10. Global Endocrinology Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Endocrinology Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Endocrinology Drugs Company, Product Type & Application Table 13. Global Endocrinology Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Endocrinology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Diabetes Drugs Table 18. Significant Companies of Human Growth Hormone Drugs Table 19. Significant Companies of Thyroid Hormone Disorder Drugs Table 20. Significant Companies of Testosterone Replacement Drugs Table 21. Global Endocrinology Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Endocrinology Drugs Sales Volume by Type (2021-2026) & (k units) Table 23. Global Endocrinology Drugs Sales Volume by Type (2027-2032) & (k units) Table 24. Global Endocrinology Drugs Sales Volume Share by Type (2021-2026) Table 25. Global Endocrinology Drugs Sales Volume Share by Type (2027-2032) Table 26. Global Endocrinology Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Endocrinology Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Endocrinology Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Endocrinology Drugs Sales Value Share by Type (2021-2026) Table 30. Global Endocrinology Drugs Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Ambulatory Care Centres Table 32. Significant Companies of Commercial Laboratories Table 33. Significant Companies of Hospitals Table 34. Significant Companies of Other Setting Table 35. Global Endocrinology Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Endocrinology Drugs Sales Volume by Application (2021-2026) & (k units) Table 37. Global Endocrinology Drugs Sales Volume by Application (2027-2032) & (k units) Table 38. Global Endocrinology Drugs Sales Volume Share by Application (2021-2026) Table 39. Global Endocrinology Drugs Sales Volume Share by Application (2027-2032) Table 40. Global Endocrinology Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Endocrinology Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Endocrinology Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Endocrinology Drugs Sales Value Share by Application (2021-2026) Table 44. Global Endocrinology Drugs Sales Value Share by Application (2027-2032) Table 45. Global Endocrinology Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Endocrinology Drugs Sales by Region (2021-2026) & (k units) Table 47. Global Endocrinology Drugs Sales Market Share by Region (2021-2026) Table 48. Global Endocrinology Drugs Sales by Region (2027-2032) & (k units) Table 49. Global Endocrinology Drugs Sales Market Share by Region (2027-2032) Table 50. Global Endocrinology Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Endocrinology Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Endocrinology Drugs Sales Value Share by Region (2021-2026) Table 53. Global Endocrinology Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Endocrinology Drugs Sales Value Share by Region (2027-2032) Table 55. Global Endocrinology Drugs Market Average Price (US$/unit) by Region (2021-2026) Table 56. Global Endocrinology Drugs Market Average Price (US$/unit) by Region (2027-2032) Table 57. Global Endocrinology Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Endocrinology Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Endocrinology Drugs Sales by Country (2021-2026) & (k units) Table 60. Global Endocrinology Drugs Sales Market Share by Country (2021-2026) Table 61. Global Endocrinology Drugs Sales by Country (2027-2032) & (k units) Table 62. Global Endocrinology Drugs Sales Market Share by Country (2027-2032) Table 63. Global Endocrinology Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Endocrinology Drugs Sales Value Market Share by Country (2021-2026) Table 65. Global Endocrinology Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Endocrinology Drugs Sales Value Market Share by Country (2027-2032) Table 67. Sanofi Company Information Table 68. Sanofi Business Overview Table 69. Sanofi Endocrinology Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Sanofi Endocrinology Drugs Product Portfolio Table 71. Sanofi Recent Development Table 72. Novo Nordisk Company Information Table 73. Novo Nordisk Business Overview Table 74. Novo Nordisk Endocrinology Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Novo Nordisk Endocrinology Drugs Product Portfolio Table 76. Novo Nordisk Recent Development Table 77. Merck Company Information Table 78. Merck Business Overview Table 79. Merck Endocrinology Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Merck Endocrinology Drugs Product Portfolio Table 81. Merck Recent Development Table 82. Eli Lilly Company Information Table 83. Eli Lilly Business Overview Table 84. Eli Lilly Endocrinology Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Eli Lilly Endocrinology Drugs Product Portfolio Table 86. Eli Lilly Recent Development Table 87. AbbVie Company Information Table 88. AbbVie Business Overview Table 89. AbbVie Endocrinology Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. AbbVie Endocrinology Drugs Product Portfolio Table 91. AbbVie Recent Development Table 92. AstraZeneca Company Information Table 93. AstraZeneca Business Overview Table 94. AstraZeneca Endocrinology Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. AstraZeneca Endocrinology Drugs Product Portfolio Table 96. AstraZeneca Recent Development Table 97. Key Raw Materials Table 98. Raw Materials Key Suppliers Table 99. Endocrinology Drugs Distributors List Table 100. Endocrinology Drugs Customers List Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Endocrinology Drugs Product Image Figure 2. Global Endocrinology Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endocrinology Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Endocrinology Drugs Sales (2021-2032) & (k units) Figure 5. Global Endocrinology Drugs Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Endocrinology Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Diabetes Drugs Image Figure 10. Human Growth Hormone Drugs Image Figure 11. Thyroid Hormone Disorder Drugs Image Figure 12. Testosterone Replacement Drugs Image Figure 13. Global Endocrinology Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Endocrinology Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Endocrinology Drugs Sales Volume Share by Type (2021-2032) Figure 16. Global Endocrinology Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Endocrinology Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Endocrinology Drugs Sales Value Share by Type (2021-2032) Figure 19. Ambulatory Care Centres Image Figure 20. Commercial Laboratories Image Figure 21. Hospitals Image Figure 22. Other Setting Image Figure 23. Global Endocrinology Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Endocrinology Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Endocrinology Drugs Sales Volume Share by Application (2021-2032) Figure 26. Global Endocrinology Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Endocrinology Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Endocrinology Drugs Sales Value Share by Application (2021-2032) Figure 29. Global Endocrinology Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Endocrinology Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Endocrinology Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Endocrinology Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Endocrinology Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. North America Endocrinology Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Endocrinology Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Endocrinology Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Endocrinology Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Endocrinology Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Endocrinology Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. South America Endocrinology Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Endocrinology Drugs Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Endocrinology Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Endocrinology Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Endocrinology Drugs Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Endocrinology Drugs Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Diabetes Drugs
  • Human Growth Hormone Drugs
  • Thyroid Hormone Disorder Drugs
  • Testosterone Replacement Drugs
Applications
  • Ambulatory Care Centres
  • Commercial Laboratories
  • Hospitals
  • Other Setting
Companies covered
  • Sanofi
  • Novo Nordisk
  • Merck
  • Eli Lilly
  • AbbVie
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Endocrinology Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Endocrinology Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Endocrinology Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Endocrinology Drugs Market Dynamics
  1. 2.1 Endocrinology Drugs Industry Trends
  2. 2.2 Endocrinology Drugs Industry Drivers
  3. 2.3 Endocrinology Drugs Industry Opportunities and Challenges
  4. 2.4 Endocrinology Drugs Industry Restraints
3 Endocrinology Drugs Market by Company
  1. 3.1 Global Endocrinology Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Endocrinology Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Endocrinology Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Endocrinology Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Endocrinology Drugs Company Ranking (2024-2026)
  6. 3.6 Global Endocrinology Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Endocrinology Drugs Company Product Type and Application
  8. 3.8 Global Endocrinology Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Endocrinology Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Endocrinology Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Endocrinology Drugs Market by Type
  1. 4.1 Endocrinology Drugs Type Introduction
  2. 4.1.1 Diabetes Drugs
  3. 4.1.2 Human Growth Hormone Drugs
  4. 4.1.3 Thyroid Hormone Disorder Drugs
  5. 4.1.4 Testosterone Replacement Drugs
  6. 4.2 Global Endocrinology Drugs Sales Volume by Type
  7. 4.2.1 Global Endocrinology Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Endocrinology Drugs Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Endocrinology Drugs Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Endocrinology Drugs Sales Value by Type
  11. 4.3.1 Global Endocrinology Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Endocrinology Drugs Sales Value by Type (2021-2032)
  13. 4.3.3 Global Endocrinology Drugs Sales Value Share by Type (2021-2032)
5 Endocrinology Drugs Market by Application
  1. 5.1 Endocrinology Drugs Application Introduction
  2. 5.1.1 Ambulatory Care Centres
  3. 5.1.2 Commercial Laboratories
  4. 5.1.3 Hospitals
  5. 5.1.4 Other Setting
  6. 5.2 Global Endocrinology Drugs Sales Volume by Application
  7. 5.2.1 Global Endocrinology Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Endocrinology Drugs Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Endocrinology Drugs Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Endocrinology Drugs Sales Value by Application
  11. 5.3.1 Global Endocrinology Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Endocrinology Drugs Sales Value by Application (2021-2032)
  13. 5.3.3 Global Endocrinology Drugs Sales Value Share by Application (2021-2032)
6 Endocrinology Drugs Regional Sales and Value Analysis
  1. 6.1 Global Endocrinology Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Endocrinology Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Endocrinology Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Endocrinology Drugs Sales by Region (2027-2032)
  5. 6.3 Global Endocrinology Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Endocrinology Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Endocrinology Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Endocrinology Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Endocrinology Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Endocrinology Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Endocrinology Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Endocrinology Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Endocrinology Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Endocrinology Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Endocrinology Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Endocrinology Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Endocrinology Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Endocrinology Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Endocrinology Drugs Sales Value Share by Country, 2025 VS 2032
7 Endocrinology Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Endocrinology Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Endocrinology Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Endocrinology Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Endocrinology Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Endocrinology Drugs Sales by Country (2027-2032)
  6. 7.4 Global Endocrinology Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Endocrinology Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Endocrinology Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Endocrinology Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Endocrinology Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Endocrinology Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Endocrinology Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Endocrinology Drugs Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Novo Nordisk
  8. 8.2.1 Novo Nordisk Company Information
  9. 8.2.2 Novo Nordisk Business Overview
  10. 8.2.3 Novo Nordisk Endocrinology Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novo Nordisk Endocrinology Drugs Product Portfolio
  12. 8.2.5 Novo Nordisk Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Endocrinology Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Endocrinology Drugs Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Eli Lilly
  20. 8.4.1 Eli Lilly Company Information
  21. 8.4.2 Eli Lilly Business Overview
  22. 8.4.3 Eli Lilly Endocrinology Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lilly Endocrinology Drugs Product Portfolio
  24. 8.4.5 Eli Lilly Recent Developments
  25. 8.5 AbbVie
  26. 8.5.1 AbbVie Company Information
  27. 8.5.2 AbbVie Business Overview
  28. 8.5.3 AbbVie Endocrinology Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 AbbVie Endocrinology Drugs Product Portfolio
  30. 8.5.5 AbbVie Recent Developments
  31. 8.6 AstraZeneca
  32. 8.6.1 AstraZeneca Company Information
  33. 8.6.2 AstraZeneca Business Overview
  34. 8.6.3 AstraZeneca Endocrinology Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 AstraZeneca Endocrinology Drugs Product Portfolio
  36. 8.6.5 AstraZeneca Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Endocrinology Drugs Value Chain Analysis
  2. 9.1.1 Endocrinology Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Endocrinology Drugs Sales Mode & Process
  6. 9.2 Endocrinology Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Endocrinology Drugs Distributors
  9. 9.2.3 Endocrinology Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst